Chongqing Genrix Biopharmaceutical Co., Ltd. (SHSE: 688443)
Health Care · Biotechnology · CN
CN¥26.36
+6.98% today · -23.0% 1Y
Chongqing Genrix Biopharmaceutical Co., Ltd. (SHSE: 688443) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.43B.
Over the last twelve months the share price has lost 23.0%, trading between 20.07 and 37.88.
Tweenvest scores Chongqing Genrix Biopharmaceutical Co., Ltd. across four factors: quality 31/100, value 78/100. Its strongest factor is value.
688443 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.43B
- Revenue (TTM)
- $40.28M
- P/E
- —
- EPS
- -1.54
- Dividend yield
- —
- Beta (5Y)
- 0.64
- 52-week high
- CN¥37.88
- 52-week low
- CN¥20.07
- Avg volume (3M)
- —
- Shares outstanding
- 366.68M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.13 | -1.75% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $441.39 | -0.19% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.54 | -0.15% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $549.64 | -0.58% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $823.30 | -1.23% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $146.41 | -7.82% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.